In this study, we employed the Cancer Genome Atlas (TCGA), UALCAN, and other databases to investigate PDCL3 expression in pan-cancer and conducted an in-depth exploration of its expression, clinical relevance, prognostic impact, and functional implications in LIHC. Here, PDCL3 is linked to cancer.